门诊唇裂修复未增加30天再入院与再手术率:4257例回顾性队列
基于NSQIP-P 2014至2023年数据,纳入4257例无合并症唇裂修复患者(单侧3695例、双侧562例),门诊手术占单侧54.5%、双侧55.2%。门诊唇裂修复与30天非计划再入院(OR 0.51,95%CI 0.22-1.10,p=0.09)及再手术(OR 2.51,95%CI 0.75-11.30,p=0.17)风险增加无关;双侧修复与再手术几率升高显著相关(OR 6.61,95%CI 2.06-21.10,p=0.001)。
要点
- 门诊唇裂修复未显著增加30天非计划再入院或再手术风险。
- 双侧唇裂修复与再手术几率升高显著相关(OR 6.61)。
- 健康患者中门诊唇裂修复30天再入院率0.78%、再手术率0.28%。
核心结论
- 门诊唇裂修复在健康患者中安全,未增加30天并发症,支持在适当情况下采用门诊诊疗。
研究设计与样本
- 回顾性队列研究,查询NSQIP-P数据库2014至2023年数据。
- 纳入4257例无合并症唇裂修复患者,其中单侧3695例、双侧562例。
主要发现
- 门诊手术占单侧唇裂修复的54.5%、双侧唇裂修复的55.2%。
- 30天非计划再入院率为0.78%,其中54.5%与唇裂修复相关。
- 非计划再手术率为0.28%,其中75.0%与唇裂修复相关。
- 双侧唇裂修复与再手术几率升高显著相关(OR 6.61,95%CI 2.06-21.10,p=0.001)。
- 门诊唇裂修复与再入院(OR 0.51,95%CI 0.22-1.10,p=0.09)及再手术(OR 2.51,95%CI 0.75-11.30,p=0.17)风险增加无关。
临床怎么用
- 健康唇裂修复患者可考虑门诊手术,未增加30天再入院或再手术风险。
- 双侧唇裂修复患者再手术几率较高,需予以关注。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cleft lip is a common craniofacial anomaly, yet standard practices for cleft lip repair (CLR), particularly regarding inpatient versus outpatient care, remain variable across clinical practice. To determine whether outpatient CLR is associated with increased 30-day readmission or reoperation rates, the National Surgery Quality Improvement Program-Pediatric (NSQIP-P) database was queried from 2014 to 2023. Cases of unilateral (UCLR) and bilateral (BCLR) cleft lip repair were identified and filtered to exclude patients with comorbidities, multiple procedures under the same anesthesia, or inpatient stays longer than one day. Postoperative unplanned readmissions, unplanned reoperations, and the reasons for unplanned admissions and reoperations were evaluated using multivariable analysis. A total of 4257 patients without comorbidities were included (3695 patients underwent UCLR and 562 patients underwent BCLR). Outpatient procedures accounted for 54.5% of UCLR and 55.2% of BCLR. The 30-day unplanned readmission rate was 0.78%, with 54.5% related to the CLR. The unplanned reoperation rate was 0.28%, with 75.0% related to the CLR. Bilateral cleft lip repair was significantly associated with higher odds of unplanned reoperation (OR: 6.61, 95% CI: 2.06-21.10, p = 0.001). Outpatient CLR was not associated with increased risk of unplanned readmission (OR: 0.51, 95% CI: 0.22-1.10, p = 0.09) or reoperation (OR: 2.51, 95% CI: 0.75-11.30, p = 0.17). These findings suggest that outpatient CLR is safe and not associated with increased 30-day complications in healthy patients, supporting the use of outpatient care when appropriate.
引用
- Gharavi A, Habermann EB, Haile D, et al. Is outpatient cleft lip repair associated with increased rates of readmission and reoperation? A retrospective cohort study of 4257 patients. J Plast Reconstr Aesthet Surg. 2025. PMID: 40382831. doi:10.1016/j.bjps.2025.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。